Ipca Laboratories Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ipca Laboratories Limited generated cash of $9,446,500,000, which is more than the previous year. Cash used in financing activities reached the amount of -$5,525,500,000 last year. Net change in cash is therefore -$8,231,900,000.
Cash Flow
| 2010 | 1.91B | -1.17B | -740.1M |
|---|---|---|---|
| 2011 | 2.11B | -1.98B | -138.3M |
| 2012 | 2.78B | -2.85B | 37M |
| 2016 | 4.91B | -2.08B | -2.12B |
| 2018 | 3.41B | -1.35B | -1.30B |
| 2020 | 5.64B | -5.09B | -1.30B |
| 2021 | 10.90B | -5.20B | -3.05B |
| 2023 | 8.05B | -7.25B | 5.07B |
| 2024 | 9.44B | -12.91B | -5.52B |
IPCALAB.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 15.78B | 9.90B | 2.95B | 3.70B | 1.42B | 1.03B | 91.4M | 107.9M | 107.4M |
Operating activities | |||||||||
Net income | 5.47B | 7.45B | 13.81B | 7.38B | 2.90B | 1.15B | 2.77B | 2.62B | 2.05B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 3.57B | 2.61B | 2.09B | 2.10B | 1.77B | 1.72B | 671.3M | 557.9M | 467.4M |
Stock-based compensation expense | 30.8M | 0 | 0 | 0 | 3.2M | 0 | 0 | 3.1M | 10.8M |
| Deferred income tax benefit | 30.8M | 0 | 0 | 0 | 3.2M | 0 | 0 | 3.1M | 10.8M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -758M | -681M | 967.5M | -1.87B | -952.6M | 1.89B | 0 | 0 | 0 |
Inventories | -929.5M | 1.14B | -2.71B | -2.39B | 16.3M | 828.6M | -1.86B | -861.7M | -740.7M |
Accounts payable | 214.9M | -324M | 559.5M | 682.8M | 263.5M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 9.44B | 8.05B | 10.90B | 5.64B | 3.41B | 4.91B | 2.78B | 2.11B | 1.91B |
Investing activities | |||||||||
Purchases Of Investments | 0 | -4.13B | -1.02B | -1.66B | -24.56B | -18.31B | 0 | -78.6M | -4.81B |
Investments In Property Plant And Equipment | -4.10B | -4.94B | -3.61B | -3.06B | -1.36B | -2.47B | -2.60B | -1.96B | -1.34B |
Acquisitions Net | -15.42B | -559.3M | -477.2M | -1.58B | 24.52B | 97.8M | -355.1M | 0 | 87.2M |
Cash generated by investing activities | -12.91B | -7.25B | -5.20B | -5.09B | -1.35B | -2.08B | -2.85B | -1.98B | -1.17B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 358.1M | 119.4M | 200K | 0 | 7.6M | 21.9M | 25.6M |
Payments for dividends | -507.4M | -1.01B | -1.01B | -1.21B | -153.2M | -153.4M | -466.6M | -438.6M | -378.7M |
Repurchases of common stock | 0 | 0 | 324.4M | 0 | 0 | 0 | 0 | 0 | -25.4M |
Repayments of term debt | -3.56B | 3.55B | -682.5M | -63.1M | -1.54B | -4.14B | -992.5M | -415.4M | -782.4M |
Cash used in financing activities | -5.52B | 5.07B | -3.05B | -1.30B | -1.30B | -2.12B | 37M | -138.3M | -740.1M |
Net Change In Cash | -8.23B | 5.88B | 2.63B | -755.3M | 753.2M | 706.2M | 15.8M | -4.3M | 500K |
Cash at end of period | 7.55B | 15.78B | 5.59B | 2.95B | 2.18B | 1.74B | 107.2M | 103.6M | 107.9M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |